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A Global Epidemic
Imagine if you suddenly felt your heart  
“jumping out of your chest” – this is the case for  
an estimated 1 in 4 Canadians who experience  
this rapid and chaotic heartbeat characteristic  
of atrial fibrillation (AF).
The healthy heart works continuously to beat 
regularly under the control of electrical impulses 
originating from the sinoatrial (SA) node, the 
heart’s natural pacemaker. In AF, electrical impulses 
do not originate in the SA node, but rather, from a 
different part of the atrium or in nearby pulmonary 
veins. These abnormal electrical signals become 
rapid and disorganized, radiating throughout the 
atrial walls in an uncoordinated manner. This can 
cause the walls of the atrium to quiver, or fibrillate, 
which results in irregular electrical transmission 
from the atria to the ventricles. A normal heart rate 
at rest should be between 60-100 beats per minute 
at rest, but in AF, it can be considerably higher than 
140 beats per minute1.
Affecting more than 33 million individuals 
worldwide, AF is the most common sustained 
irregular heart rhythm encountered in clinical 
practice2. The progression and maintenance of AF 
results in adverse events, including an increase 
in hospitalizations and a five-fold increase in the 
risk of stroke3. Given this evidence and anticipated 
increases in life expectancy within the next several 
decades, there are clear public health implications 
for the aging Canadian population.
The Evidence is Heavy
Over the years, I have witnessed a paradigm 
shift in the treatment of AF. I recall being first 
exposed to the field more than 5 years ago 
when AF management focused largely on highly 
invasive surgery and oral anticoagulation or 
“blood thinners”. In many cases, these treatment 
options may be the closest to a “cure” for patients. 
However, there has been considerable evidence 
to suggest that a stocked medicine cabinet or an 
abundance of sophisticated technical equipment 
may not necessarily be the solution.
With each patient that arrived to clinic, I began 
to notice a pattern of symptoms and conditions. 
These patients often presented with existing 
conditions, such as hypertension and diabetes, 
and precipitating lifestyle habits, such as excessive 
smoking and alcohol consumption. Not only do 
these conditions and habits lead to the incidence 
and worsening of AF, but significantly increase a 
patient’s risk of stroke. In fact, nearly 60% of AF 
can be attributable to these so-called modifiable 
risk factors4.
For these reasons, we hypothesized that  
treating the development of AF may require  
early identification of these modifiable risk 
factors so that we can intervene before patients 
worsen and require invasive treatment.
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From years of working with these patients, 
I have come to realize that a key focus in 
AF management is not simply targeting the 
physiological symptoms, but their psychology as 
well. Understanding how the patient feels as well 
as how to improve their overall psychosocial  
well-being is critical to their treatment.
In designing a scalable, reproducible, and econo-
mical lifestyle modification program, it is also of 
critical importance that we evaluate the impact  
of lifestyle practices on patient symptoms. Taken 
together, these results may have significant clinical 
and socioeconomic implications for the aging 
population worldwide if shown to effectively treat 
the progression of AF. AF is one of the higher cost 
chronic conditions in the Canadian health care 
system and early interventions may contribute 
to reducing rates of AF-related hospitalizations 
through primary stroke prevention. Additionally, 
there are numerous stroke risk factors, which 
independently contribute to the initiation of 
AF. Just to name a few – hypertension (HTN), 
diabetes mellitus (DM), obesity, and obstructive 
sleep apnea (OSA).
There have been several lifestyle modification 
strategies that have shown to be feasible in 
the treatment of AF. For example, there is 
overwhelming evidence to suggest that dietary 
changes may prevent the progression of impaired 
glucose tolerance to diabetes. Specifically, 
adherence to a diet characterized by a high 
consumption of fruits and vegetables, and a low 
consumption of red meat products, may have 
beneficial effects for cardiovascular health5. 
Previously, studies have correlated the traditional 
Mediterranean diet to reductions in heart disease, 
which may be attributable to lower levels of  
low oxidized low-density lipoprotein (LDL).  
LDL is often referred to as “bad cholesterol” as it 
contributes to buildup in the arteries and ultimately, 
narrowing of the arteries. Elevated levels of LDL are 
associated with increased risk of atherosclerosis, 
however the exact role of diet on cardiovascular 
disease events remains somewhat unknown which 
may be an important consideration when creating 
diet prescriptions for AF patients.
Weight management has also been shown  
to have significant implications for patients 
with elevated body mass indexes (BMI) and AF. 
In the LEGACY trial conducted by Pathak and 
colleagues6, patients with a known history of AF 
underwent intentional, goal-directed weight loss 
as defined by a ≥10% reduction in their baseline 
weight. This group of patients experienced a 
6-fold greater probability of arrhythmia-free 
survival as compared to those with little- to no- 
weight change. In another study, adherence to 
guideline recommendations of 150 min/week of 
exercise led participants to experience a 22% lower 
risk of death or major adverse cardiac events7.
Finally, although previous studies have attempted 
to establish the optimal diet and weight  
management strategies for patients with AF, 
these interventions have failed to achieve the 
desired results through long-term adherence.  
The administration of dietary advice and exercise 
prescriptions may in fact, be heavily influenced 
by psychological factors and therefore, could 
be enhanced through the use of positive 
reinforcement techniques. This is strengthened 
by prior evidence demonstrating that lifestyle 
behaviour change services delivered in a hospital 
setting is indeed feasible, with the appropriate 
techniques8. Therefore, adopting a holistic 
approach to patient management and treatment, 
which integrates positive reinforcement while 
addressing the social determinants of health and 
behavioural change, may facilitate the translation 
of these lifestyle practices into long-term habit.
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Atrial fibrillation is a global epidemic of the 
21st century and the delivery of early lifestyle 
interventions has the potential to revolutionize 
treatment and avoid the need for invasive surgical 
treatment altogether. At our institution, we are  
eager to implement these strategies and have  
recently commenced our own lifestyle modi-
fication program. This is part of our team’s overall 
goal of discovering innovative treatment options 
for this difficult condition. Other exciting work 
by our team includes performing the first hybrid 
catheter ablation in the nation – a safer and  
more tailored procedure for patients with  
severe forms of AF.
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